CA2219683A1 - Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes - Google Patents

Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes

Info

Publication number
CA2219683A1
CA2219683A1 CA 2219683 CA2219683A CA2219683A1 CA 2219683 A1 CA2219683 A1 CA 2219683A1 CA 2219683 CA2219683 CA 2219683 CA 2219683 A CA2219683 A CA 2219683A CA 2219683 A1 CA2219683 A1 CA 2219683A1
Authority
CA
Canada
Prior art keywords
myelin
spinal
complement
spinal cord
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CA 2219683
Other languages
English (en)
Inventor
John D. Steeves
Jason K. Dyer
Hans S. Keirstead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2219683 priority Critical patent/CA2219683A1/fr
Priority to DE69818106T priority patent/DE69818106T2/de
Priority to CA 2253078 priority patent/CA2253078C/fr
Priority to ES98949847T priority patent/ES2210829T3/es
Priority to EP98949847A priority patent/EP1047449B1/fr
Priority to US09/530,234 priority patent/US6969516B1/en
Priority to PT98949847T priority patent/PT1047449E/pt
Priority to DK98949847T priority patent/DK1047449T3/da
Priority to US09/181,719 priority patent/US6548061B1/en
Priority to AU96179/98A priority patent/AU748143B2/en
Priority to PCT/CA1998/000997 priority patent/WO1999021581A1/fr
Priority to AT98949847T priority patent/ATE249241T1/de
Priority to IL13579998A priority patent/IL135799A0/xx
Priority to JP2000517739A priority patent/JP2001521008A/ja
Publication of CA2219683A1 publication Critical patent/CA2219683A1/fr
Priority to IL135799A priority patent/IL135799A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA 2219683 1997-10-28 1997-10-28 Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes Withdrawn CA2219683A1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CA 2219683 CA2219683A1 (fr) 1997-10-28 1997-10-28 Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes
DK98949847T DK1047449T3 (da) 1997-10-28 1998-10-28 Immunologiske præparater og anvendelse deraf til forbigående ændring af myelin i centralnervesystemet hos pattedyr for at fremme neuronal regenerering
US09/181,719 US6548061B1 (en) 1997-10-28 1998-10-28 Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration
ES98949847T ES2210829T3 (es) 1997-10-28 1998-10-28 Composicion y proceso inmunologico utilizados para modificar transitoriamente la melina del sistema nervioso central de mamiferos para estimular la regeneracion neuronal.
EP98949847A EP1047449B1 (fr) 1997-10-28 1998-10-28 Compositions et procedes immunologiques utilises pour modifier provisoirement la myeline du systeme nerveux central des mammiferes afin de stimuler la regeneration neuronale
US09/530,234 US6969516B1 (en) 1997-10-28 1998-10-28 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
PT98949847T PT1047449E (pt) 1997-10-28 1998-10-28 Composicoes imunologicas e metodos de utilizacao para alterar transitoriamente a mielina do sistema nervoso central mamifero para promover a regeneracao neuronal
DE69818106T DE69818106T2 (de) 1997-10-28 1998-10-28 Immunologische zusammensetzungen und verfahren zur transienten änderung des zentralnervensystem-myelins der saügetiere und förderung der nerven-regenerierung
CA 2253078 CA2253078C (fr) 1997-10-28 1998-10-28 Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones
AU96179/98A AU748143B2 (en) 1997-10-28 1998-10-28 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
PCT/CA1998/000997 WO1999021581A1 (fr) 1997-10-28 1998-10-28 Compositions et procedes immunologiques utilises pour modifier provisoirement la myeline du systeme nerveux central des mammiferes afin de stimuler la regeneration neuronale
AT98949847T ATE249241T1 (de) 1997-10-28 1998-10-28 Immunologische zusammensetzungen und verfahren zur transienten änderung des zentralnervensystem- myelins der saügetiere und förderung der nerven- regenerierung
IL13579998A IL135799A0 (en) 1997-10-28 1998-10-28 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
JP2000517739A JP2001521008A (ja) 1997-10-28 1998-10-28 哺乳類の中枢神経系ミエリンを一過的に変えて神経再生を促進する免疫組成物及びその使用方法
IL135799A IL135799A (en) 1997-10-28 2000-04-24 Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2219683 CA2219683A1 (fr) 1997-10-28 1997-10-28 Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes

Publications (1)

Publication Number Publication Date
CA2219683A1 true CA2219683A1 (fr) 1999-04-28

Family

ID=29275133

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2219683 Withdrawn CA2219683A1 (fr) 1997-10-28 1997-10-28 Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes

Country Status (1)

Country Link
CA (1) CA2219683A1 (fr)

Similar Documents

Publication Publication Date Title
Lassmann et al. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions
Popovich et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury
Lunn et al. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve
Woodruff et al. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti‐galactocerebroside: A comparative study
Weibel et al. Regeneration of lesioned rat optic nerve fibers is improved after neutralization of myelin-associated neurite growth inhibitors
Dyer et al. Regeneration of brainstem-spinal axons after lesion and immunological disruption of myelin in adult rat
DE69736976T2 (de) Mit Alzheimer Krankheit verknüpften Verfahren zur Diagnose, zur Herstellung von Medikamenten und zum Screenen von Substanzen sowie aus Beta-Amyloid abgeleiteten Peptiden
Chen et al. Evaluation of a competitive NMDA antagonist (D‐CPPene) in feline focal cerebral ischemia
JP5646617B2 (ja) 多発性硬化症の治療のための組成物および方法
Yu et al. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer’s disease
US6165515A (en) Method for treatment of osteoporosis
Bai et al. Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment
JPH10508487A (ja) ブタ中脳細胞、および神経変性疾患による神経的欠乏の処置におけるその使用
EP1047449B1 (fr) Compositions et procedes immunologiques utilises pour modifier provisoirement la myeline du systeme nerveux central des mammiferes afin de stimuler la regeneration neuronale
CN103028110A (zh) 抗分泌因子的新用途
Ajenikoko et al. Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction
Nishi et al. Hemifacial spasm due to contralateral acoustic neuroma: case report
JP2002544233A (ja) 老人性痴呆症の治療に適した平均分子量が２，４００ｄに等しいグリコサミノグリカン
Okada et al. Intravitreal macrophage activation enables cat retinal ganglion cells to regenerate injured axons into the mature optic nerve
Bäckman et al. Effects of transferrin receptor antibody—NGF conjugate on young and aged septal transplants in oculo
US20180318379A1 (en) Inhibition of triggering receptor expressed on myeloid cells 1 (trem1) to treat central nervous system disorders
CA2253078C (fr) Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones
CA2219683A1 (fr) Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes
US20050008641A1 (en) Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
WO2000064473A1 (fr) Composition pour la regeneration neuronale, comprenant des anticorps specifiques de la myeline et des complements

Legal Events

Date Code Title Description
AZWI Withdrawn application